Andrew Sealfon - Repro Med Insider

Repro Med Systems Inc -- USA Stock  

USD 0.96  0.02  2.04%

Co-Founder, Chairman, CEO and President and Head of RandD

Mr. Andrew I. Sealfon was appointed as Chairman of the Board, President of ReproMed Systems Inc. Mr. Andrew Sealfon cofounded Repro Med Systems, Inc. in 1980. He is an electrical engineer and inventor and was granted numerous U.S. patents. Mr. Sealfon is a graduate of Lafayette College.
Age: 69  Chairman Since 2017      

Management Efficiency

The company has return on total asset (ROA) of (5.56) % which means that it has lost $5.56 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (7.76) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 3 records


Jeffrey EberweinDigirad Corporation
Michael MussallemEdwards Lifesciences Corporatio
Erez RaphaelDarioHealth Corp

Entity Summary

Repro Med Systems, Inc. designs, manufactures, and markets proprietary medical devices primarily for the ambulatory infusion market and emergency medical applications worldwide. Repro Med Systems Inc (REPR) is traded on OTC Market in USA. It is located in NEW YORK, U.S.A and employs 55 people. Repro Med is listed under Medical Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Repro Med Systems Inc to your portfolio

Top Management

Repro Med Systems Leadership Team
Karen Fisher, CFO
Fred Ma, Executive, Ph.D
Mark Pastreich, Director
Cyril Narishkin, Director
Andrew Sealfon, Chairman
David Anderson, Director
Paul Baker, Director
Brad Sealfon, Director
Eric Bauer, COO
Arthur Radin, Director
Joseph Manko, Director

Stock Performance

Repro Med Performance Indicators